Clustering data with hclust algorithm for (Study ST000663)

(Analysis AN001012)
MetaboliteStructureF1F2F3F4
PS 38:4; [M-H]-@6.08ME1787301.111.750.590.56
PC 31:0; [M-Ac-H]-@6.26ME1786321.120.980.741.16
PC 29:0; [M-Ac-H]-@5.57ME1786281.520.760.970.74
PC 28:0; [M-Ac-H]-@5.23ME1786271.330.711.240.71
PI 38:6; [M-H]-@5.24ME1787261.370.731.140.75
plasmenyl-PE 42:6; [M-H]-@7.77ME1787651.310.771.120.80
PE 40:6; [M-H]-@6.92ME1787110.930.671.351.06
PC 35:5; [M-Ac-H]-@5.49ME1786520.760.851.570.82
CL 82:13; [M-2H](2-)@6.39ME1786030.960.671.510.85
CerP 32:1; [M-H]-@5.15ME1786050.930.841.430.80
FFA(24:3)ME1786210.980.771.530.72
lysoPE 22:4; [M-H]-@1.92ME1787380.821.151.340.68
PA 38:6; [M-H]-@6.11ME1786260.931.120.921.03
PI 38:3; [M-H]-@6.20ME1787230.981.150.861.00
plasmenyl-PE 34:2; [M-H]-@6.75ME1787440.911.200.980.90
plasmenyl-PE 38:4; [M-H]-@7.24ME1787540.871.190.970.96
plasmenyl-PE 38:4; [M-H]-@7.37ME1787550.871.190.970.96
PG 36:2; [M-H]-@6.15ME1787150.811.290.930.98
plasmenyl-PE 34:3; [M-H]-@6.34ME1787450.891.290.880.94
PE 36:1; [M-H]-@6.69ME1786960.901.071.220.81
PE 36:1; [M-H]-@7.44ME1786950.921.081.250.74
PC 32:1; [M-Ac-H]-@6.08ME1786351.001.071.090.84
PE 34:3; [M-H]-@6.07ME1786901.001.091.110.80
PC 40:4; [M-Ac-H]-@7.30ME1786750.951.031.130.88
plasmenyl-PE 40:3; [M-H]-@8.07ME1787580.951.041.100.92
PE 38:2; [M-H]-@7.58ME1787041.031.211.130.62
PE 36:3; [M-H]-@5.24ME1786981.031.181.030.76
PC 31:1; [M-Ac-H]-@5.76ME1786330.981.181.050.79
PE 36:2; [M-H]-@5.72ME1786971.001.141.070.78
PC 34:5; [M-Ac-H]-@5.14ME1786470.881.231.140.75
PE 40:4; [M-H]-@7.44ME1787090.921.221.080.78
plasmenyl-PE 40:4; [M-H]-@7.77ME1787590.921.320.960.81
PS 38:5; [M-H]-@5.64ME1787310.991.420.830.76
PS 36:1; [M-H]-@6.48ME1787291.121.290.980.61
PE 35:4; [M-H]-@6.08ME1786931.141.140.910.80
PC 33:0; [M-Ac-H]-@6.79ME1786381.061.220.930.79
PE 35:1; [M-H]-@7.13ME1786911.091.170.950.79
FFA(20:1)ME1786120.791.031.181.00
FFA(22:3)ME1786170.741.051.220.99
FFA(18:1)ME1786090.771.021.141.07
FFA(18:2)ME1786100.770.991.141.09
plasmenyl-PE 34:1; [M-H]-@7.19ME1787430.760.991.141.11
Arachidonic acidME1785930.750.971.211.07
FFA(20:2)ME1786130.710.991.211.09
lysoPE 22:5; [M-H]-@1.56ME1787390.861.061.100.98
PG 38:4; [M-H]-@6.14ME1787170.831.101.110.96
PE 40:5; [M-H]-@7.11ME1787100.850.931.111.10
lysoPE 20:4; [M-H]-@1.38ME1787370.870.971.121.03
PE 38:1; [M-H]-@7.88ME1787030.841.021.121.03
PE 38:3; [M-H]-@7.25ME1787050.881.041.041.03
plasmenyl-PE 36:1; [M-H]-@7.73ME1787460.931.041.021.01
CL 78:5; [M-2H](2-)@7.25ME1786000.921.011.061.00
PE 38:4; [M-H]-@6.97ME1787060.931.021.070.98
FFA(16:0)ME1786070.940.941.111.02
PE 36:0; [M-H]-@7.84ME1786940.940.961.031.07
plasmenyl-PE 32:1; [M-H]-@6.62ME1787410.651.051.320.98
plasmenyl-PE 36:4; [M-H]-@6.67ME1787490.751.091.280.88
PC 30:2; [M-Ac-H]-@4.91ME1786310.731.021.340.90
PC 39:5; [M-Ac-H]-@6.62ME1786720.761.001.320.92
PC 40:6; [M-Ac-H]-@6.72ME1786770.810.941.370.89
PE 37:4; [M-H]-@6.70ME1787020.870.971.340.82
PI 40:5; [M-H]-@6.08ME1787270.910.991.320.78
PC 35:4; [M-Ac-H]-@5.93ME1786510.880.961.250.91
plasmenyl-PE 38:5; [M-H]-@6.78ME1787560.920.961.230.89
PA 34:0; [M-H]-@7.49ME1786240.900.941.200.96
PC 40:5; [M-Ac-H]-@7.04ME1786760.910.931.200.96
PC 34:4; [M-Ac-H]-@5.55ME1786460.930.961.180.92
PC 38:3; [M-Ac-H]-@7.06ME1786650.910.991.150.95
PC 37:5; [M-Ac-H]-@6.03ME1786620.830.891.251.03
PC 38:4; [M-Ac-H]-@6.75ME1786660.830.891.251.02
CL 82:9; [M-2H](2-)@7.10ME1786040.860.871.280.99
PC 37:4; [M-Ac-H]-@6.52ME1786610.840.911.270.98
PC 36:4; [M-Ac-H]-@6.08ME1786560.860.911.250.98
PC 38:5; [M-Ac-H]-@6.33ME1786680.860.921.250.98
PC 38:5; [M-Ac-H]-@6.55ME1786670.860.921.250.98
FFA(22:2)ME1786160.830.981.270.92
PC 42:10; [M-Ac-H]-@5.73ME1786800.810.981.240.97
PE 40:7; [M-H]-@6.41ME1787121.000.771.340.89
PC 37:3; [M-Ac-H]-@6.73ME1786600.920.891.280.91
PE 36:5; [M-H]-@6.04ME1787010.930.891.270.91
FFA(24:2)ME1786200.940.841.330.89
PC 36:5; [M-Ac-H]-@5.66ME1786570.890.861.330.91
plasmenyl-PE 38:6; [M-H]-@6.57ME1787570.900.851.340.91
lysoPE 22:6; [M-H]-@1.33ME1787400.880.801.281.04
PA 34:0; [M-H]-@5.19ME1786230.830.811.400.96
CL 74:1; [M-2H](2-)@7.42ME1785960.981.001.360.66
PC 30:1; [M-Ac-H]-@5.40ME1786301.051.001.300.64
CL 74:7; [M-2H](2-)@6.10ME1785991.040.871.310.79
PC 40:8; [M-Ac-H]-@5.79ME1786791.050.881.250.82
CL 78:9; [M-2H](2-)@6.53ME1786021.010.911.250.82
PC 39:6; [M-Ac-H]-@6.40ME1786731.010.881.250.85
CL 78:7; [M-2H](2-)@6.72ME1786010.940.981.260.82
PC 39:4; [M-Ac-H]-@7.09ME1786710.990.931.290.78
PE 38:5; [M-H]-@6.55ME1787070.970.911.280.83
plasmenyl-PE 36:5; [M-H]-@6.35ME1787500.960.921.310.81
CL 70:5; [M-2H](2-)@6.08ME1785951.041.001.210.75
PE 36:4; [M-H]-@6.26ME1787001.030.951.200.82
PG 36:3; [M-H]-@5.43ME1787161.020.961.210.81
PC 32:0; [M-Ac-H]-@6.58ME1786341.070.891.170.87
PC 34:1; [M-Ac-H]-@6.62ME1786431.070.921.200.81
PC 34:1; [M-Ac-H]-@6.69ME1786421.070.921.200.81
PC 32:2; [M-Ac-H]-@5.59ME1786361.070.911.180.84
PE 34:2; [M-H]-@6.43ME1786881.080.891.190.83
PC 30:0; [M-Ac-H]-@5.96ME1786291.270.811.240.68
PC 32:3; [M-Ac-H]-@5.15ME1786371.190.851.290.67
CL 74:5; [M-2H](2-)@6.61ME1785981.150.811.290.75
PE 36:3; [M-H]-@6.56ME1786991.110.871.260.76
lysoPE 18:1; [M-H]-@1.87ME1787341.140.881.170.81
PE 34:1; [M-H]-@6.86ME1786871.160.891.190.76
CL 70:1; [M-2H](2-)@6.86ME1785941.210.811.190.80
FFA(22:1)ME1786151.250.841.140.77
plasmenyl-PE 42:4; [M-H]-@8.19ME1787631.091.021.140.74
PE 32:1; [M-H]-@6.27ME1786841.151.011.120.72
PI 36:1; [M-H]-@6.40ME1787201.180.961.130.72
PC 44:4; [M-Ac-H]-@8.45ME1786831.320.901.010.77
plasmenyl-PE 38:1; [M-H]-@8.22ME1787511.240.931.070.76
PI 34:1; [M-H]-@5.77ME1787181.221.031.010.74
PI 36:2; [M-H]-@6.01ME1787211.231.041.010.72
PC 42:4; [M-Ac-H]-@7.97ME1786821.201.050.940.81
PG 34:2; [M-H]-@5.57ME1787141.161.030.980.82
lysoPE 16:0; [M-H]-@1.70ME1787321.300.761.030.91
PC 37:2; [M-Ac-H]-@7.17ME1786591.280.830.990.90
FFA(24:0)ME1786181.240.891.010.86
lysoPE 18:2; [M-H]-@1.40ME1787351.180.891.050.88
PC 42:2; [M-Ac-H]-@8.50ME1786811.250.940.900.91
PE 35:2; [M-H]-@6.72ME1786921.170.950.940.95
PI 38:5; [M-H]-@5.48ME1787251.180.930.950.94
PC 35:1; [M-Ac-H]-@6.99ME1786481.170.960.970.89
PI 34:2; [M-H]-@5.37ME1787191.141.010.970.88
plasmenyl-PE 38:2; [M-H]-@7.88ME1787521.071.050.940.93
PC 35:3; [M-Ac-H]-@6.11ME1786501.080.970.931.01
PE 33:2; [M-H]-@6.10ME1786850.981.010.991.03
PS 34:0; [M-H]-@6.36ME1787281.020.981.001.00
PG 34:0; [M-H]-@6.40ME1787131.001.001.001.00
PI 37:4; [M-H]-@5.66ME1787221.001.001.001.00
PC 34:0; [M-Ac-H]-@7.16ME1786411.010.991.001.00
PE 34:0; [M-H]-@7.27ME1786861.011.001.001.00
PE 34:2; [M-H]-@5.10ME1786891.060.990.990.97
plasmenyl-PE 36:2; [M-H]-@7.35ME1787471.070.980.980.96
lysoPE 20:3; [M-H]-@1.66ME1787361.030.961.020.99
plasmenyl-PE 38:3; [M-H]-@7.48ME1787531.040.991.020.96
PC 34:3; [M-Ac-H]-@5.76ME1786451.000.931.170.90
FFA(18:0)ME1786081.000.931.100.97
PI 38:4; [M-H]-@5.99ME1787241.010.921.120.95
MGDG 22:1; [M-H]-@1.48ME1786221.000.941.130.94
PC 36:3; [M-Ac-H]-@6.40ME1786551.000.941.130.93
PC 33:1; [M-Ac-H]-@6.42ME1786390.980.981.120.92
plasmenyl-PE 34:0; [M-H]-@7.24ME1787421.020.961.110.90
plasmenyl-PE 42:5; [M-H]-@7.88ME1787641.011.001.110.88
plasmenyl-PE 40:5; [M-H]-@7.34ME1787611.001.001.070.93
plasmenyl-PE 40:5; [M-H]-@7.45ME1787601.001.001.070.93
PC 33:2; [M-Ac-H]-@5.96ME1786401.030.961.070.94
plasmenyl-PE 36:3; [M-H]-@6.90ME1787481.020.951.060.97
FFA(22:0)ME1786141.130.881.030.96
FFA(20:0)ME1786111.080.921.050.95
PC 38:2; [M-Ac-H]-@7.43ME1786641.100.941.030.94
PC 36:2; [M-Ac-H]-@6.82ME1786541.110.901.090.89
lysoPE 18:0; [M-H]-@2.45ME1787331.070.921.110.90
PC 35:2; [M-Ac-H]-@6.54ME1786491.060.951.110.88
PC 36:1; [M-Ac-H]-@7.26ME1786531.070.941.110.89
PC 40:3; [M-Ac-H]-@7.61ME1786741.110.941.130.82
CL 74:3; [M-2H](2-)@6.97ME1785971.130.971.060.85
PC 34:2; [M-Ac-H]-@6.21ME1786441.100.951.090.86
PA 34:0; [M-H]-@6.91ME1786251.200.711.160.92
PC 40:7; [M-Ac-H]-@6.25ME1786780.970.791.240.99
FFA(24:1)ME1786191.070.811.220.89
PC 38:7; [M-Ac-H]-@5.54ME1786701.060.831.220.89
PE 38:6; [M-H]-@6.18ME1787081.040.801.170.98
PC 36:6; [M-Ac-H]-@5.45ME1786581.050.801.200.95
PC 38:6; [M-Ac-H]-@6.01ME1786691.020.801.220.95
CerP 34:1; [M-H]-@5.86ME1786061.100.731.131.04
PC 37:6; [M-Ac-H]-@5.82ME1786631.090.821.031.06
plasmenyl-PE 40:6; [M-H]-@7.21ME1787621.040.851.111.01

Factors:

F1control:Control | visit:Control
F2control:Metabolic syndrom | visit:MS Visit 1
F3control:Metabolic syndrom | visit:MS Visit 3
F4control:Metabolic syndrom | visit:MS Visit 4
Data matrix
  logo